Evaluation of efficacy and safety of esmolol in treating patients with septic shock
Abstract. Background:. In septic shock cases, tachycardia and a hyperdynamic hemodynamic profile are characteristics of the condition. It has been reported that using beta antagonist esmolol constitutes a form of treatment to reduce heart rate to improve diastolic filling time and elevate cardiac ou...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-04-01
|
Series: | Medicine |
Online Access: | http://journals.lww.com/10.1097/MD.0000000000029124 |